222 related articles for article (PubMed ID: 32070160)
1. Neuropathic pain: preclinical and early clinical progress with voltage-gated sodium channel blockers.
Kushnarev M; Pirvulescu IP; Candido KD; Knezevic NN
Expert Opin Investig Drugs; 2020 Mar; 29(3):259-271. PubMed ID: 32070160
[No Abstract] [Full Text] [Related]
2. Voltage-gated Na+ channels in neuropathic pain.
Hargus NJ; Patel MK
Expert Opin Investig Drugs; 2007 May; 16(5):635-46. PubMed ID: 17461737
[TBL] [Abstract][Full Text] [Related]
3. Novel sodium channel antagonists in the treatment of neuropathic pain.
Rivara M; Zuliani V
Expert Opin Investig Drugs; 2016; 25(2):215-26. PubMed ID: 26576738
[TBL] [Abstract][Full Text] [Related]
4. Identification of WB4101, an
Li M; Wu Y; Zou B; Wang X; Li M; Yu H
Mol Pharmacol; 2018 Aug; 94(2):896-906. PubMed ID: 29884692
[TBL] [Abstract][Full Text] [Related]
5. The roles of sodium channels in nociception: implications for mechanisms of neuropathic pain.
Liu M; Wood JN
Pain Med; 2011 Jul; 12 Suppl 3():S93-9. PubMed ID: 21752183
[TBL] [Abstract][Full Text] [Related]
6. Sodium channel blockers for neuropathic pain.
Zuliani V; Rivara M; Fantini M; Costantino G
Expert Opin Ther Pat; 2010 Jun; 20(6):755-79. PubMed ID: 20384535
[TBL] [Abstract][Full Text] [Related]
7. HYP-17, a novel voltage-gated sodium channel blocker, relieves inflammatory and neuropathic pain in rats.
Lee JY; Kam YL; Oh J; Kim DH; Choi JS; Choi HY; Han S; Youn I; Choo HP; Yune TY
Pharmacol Biochem Behav; 2017 Feb; 153():116-129. PubMed ID: 28024908
[TBL] [Abstract][Full Text] [Related]
8. Scorpion Toxins Targeting Voltage-gated Sodium Channels Associated with Pain.
Xu Y; Sun J; Liu H; Sun J; Yu Y; Su Y; Cui Y; Zhao M; Zhang J
Curr Pharm Biotechnol; 2018; 19(11):848-855. PubMed ID: 30398114
[TBL] [Abstract][Full Text] [Related]
9. Development of a Rapid Throughput Assay for Identification of hNav1.7 Antagonist Using Unique Efficacious Sodium Channel Agonist, Antillatoxin.
Zhao F; Li X; Jin L; Zhang F; Inoue M; Yu B; Cao Z
Mar Drugs; 2016 Feb; 14(2):. PubMed ID: 26891306
[TBL] [Abstract][Full Text] [Related]
10. DRG Voltage-Gated Sodium Channel 1.7 Is Upregulated in Paclitaxel-Induced Neuropathy in Rats and in Humans with Neuropathic Pain.
Li Y; North RY; Rhines LD; Tatsui CE; Rao G; Edwards DD; Cassidy RM; Harrison DS; Johansson CA; Zhang H; Dougherty PM
J Neurosci; 2018 Jan; 38(5):1124-1136. PubMed ID: 29255002
[TBL] [Abstract][Full Text] [Related]
11. The neurosteroid allopregnanolone sulfate inhibits Na
Horishita T; Yanagihara N; Ueno S; Okura D; Horishita R; Minami T; Ogata Y; Sudo Y; Uezono Y; Kawasaki T
J Pharmacol Sci; 2018 May; 137(1):93-97. PubMed ID: 29773519
[TBL] [Abstract][Full Text] [Related]
12. Elucidation of pathophysiology and treatment of neuropathic pain.
Vranken JH
Cent Nerv Syst Agents Med Chem; 2012 Dec; 12(4):304-14. PubMed ID: 23033930
[TBL] [Abstract][Full Text] [Related]
13. A Novel Toxin from Haplopelma lividum Selectively Inhibits the Na
Meng P; Huang H; Wang G; Yang S; Lu Q; Liu J; Lai R; Rong M
Toxins (Basel); 2016 Dec; 9(1):. PubMed ID: 28035974
[TBL] [Abstract][Full Text] [Related]
14. Selective Voltage-Gated Sodium Channel Peptide Toxins from Animal Venom: Pharmacological Probes and Analgesic Drug Development.
Wu Y; Ma H; Zhang F; Zhang C; Zou X; Cao Z
ACS Chem Neurosci; 2018 Feb; 9(2):187-197. PubMed ID: 29161016
[TBL] [Abstract][Full Text] [Related]
15. Conotoxins targeting neuronal voltage-gated sodium channel subtypes: potential analgesics?
Knapp O; McArthur JR; Adams DJ
Toxins (Basel); 2012 Nov; 4(11):1236-60. PubMed ID: 23202314
[TBL] [Abstract][Full Text] [Related]
16. Voltage gated sodium and calcium channel blockers for the treatment of chronic inflammatory pain.
Rahman W; Dickenson AH
Neurosci Lett; 2013 Dec; 557 Pt A():19-26. PubMed ID: 23941888
[TBL] [Abstract][Full Text] [Related]
17. The Natural Flavonoid Naringenin Elicits Analgesia through Inhibition of NaV1.8 Voltage-Gated Sodium Channels.
Zhou Y; Cai S; Moutal A; Yu J; Gómez K; Madura CL; Shan Z; Pham NYN; Serafini MJ; Dorame A; Scott DD; François-Moutal L; Perez-Miller S; Patek M; Khanna M; Khanna R
ACS Chem Neurosci; 2019 Dec; 10(12):4834-4846. PubMed ID: 31697467
[TBL] [Abstract][Full Text] [Related]
18. Discovery of a Novel Class of State-Dependent Na
Tanaka K; Kobayashi H; Suzuki S; Shibuya S; Kimoto H; Domon Y; Kubota K; Kitano Y; Yokoyama T; Shimizugawa A; Koishi R; Fujiwara C; Asano D; Shinozuka T
Chem Pharm Bull (Tokyo); 2020; 68(7):653-663. PubMed ID: 32612000
[TBL] [Abstract][Full Text] [Related]
19. Chimeric agents derived from the functionalized amino acid, lacosamide, and the α-aminoamide, safinamide: evaluation of their inhibitory actions on voltage-gated sodium channels, and antiseizure and antinociception activities and comparison with lacosamide and safinamide.
Park KD; Yang XF; Dustrude ET; Wang Y; Ripsch MS; White FA; Khanna R; Kohn H
ACS Chem Neurosci; 2015 Feb; 6(2):316-30. PubMed ID: 25418676
[TBL] [Abstract][Full Text] [Related]
20. Future potential and status of selective sodium channel blockers for the treatment of pain.
Priest BT
Curr Opin Drug Discov Devel; 2009 Sep; 12(5):682-92. PubMed ID: 19736626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
